Wednesday, February 24, 2010

Answers to Webcast Questions - Leveraging ICH Q9 / ISO 14971 in Support of IS Compliance

Thanks to everyone who attended the webcast "Leveraging ICH Q9 / ISO 14971 in Support of IS Compliance" and who submitted questions. The recording is now on-line and subscribers can download the slides from the Business & Decision website as usual.

Listed below are the questions that we didn't have time for in the live webcast, along with the answers we promised to provide.


Q. Do you find that IT teams want to take the time to conduct proper risk assessments?
A. It all depends on the risk assessment process and model, whether it is scaled appropriately to the project / system and how well trained the IT team is. Assessing the risk severity is best left to the quality / regulatory and business subject matter experts, leaving the IT staff to think about technical risk scenarios and the risk likelihood and detectability.
Most professional IT staff evaluate and mitigate risk on an automatic basis, at least as far as the technology is concerned. For example, if it’s a critical business system the IT team will usually suggest redundant discs or mirroring to a DR site as a matter of course. In many cases you need them to reverse engineer their logic and document the rationale for their decisions using appropriately scaled tools and templates.
If you can make it clear to the IT staff that their expertise is valued and respected, that we just want them to rationalize and document their decisions with a process that isn’t too onerous we usually find that there is good buy-in

Q. Why do all your risk diagrams or maps make a low impact/high probability event equivalent to a high impact/low probability event....surely this is both misleading and dangerous.
A. They’re not our diagrams and maps – they are from the GAMP® Guide or GAMP® Good Practice Guides. Using the GAMP® risk assessment model gives Risk Class 2 for both high severity/low likelihood and low severity/high likelihood.
Equating severity and likelihood in the way wouldn’t be wise and could possibly increase the possibility of an unacceptable risk being seen as acceptable when considering the hazards associated with a medical device or risk to a patient through the use of a new drug. However, GAMP® attempts to provide a relatively simple risk assessment model which is cost effective when used in the implementation of computerized systems.
What wasn’t shown in the project example included in this webcast were the specific criteria used to qualitatively assess risk severity and risk likelihood, and which erred in the side of caution for this relatively high risk project/system.

Q. Can you comment on how pressure testing a system can provide data on probability of failure?
A. Assuming that ‘pressure testing’ relates to the stress testing of software rather than the pressure testing of a process vessel, it can only provide a limited set of data on the probability of failure. Because software does not change over time (assuming effective change control and configuration management processes) stress testing has little value in terms of the software functionality. Boundary, structural (path & branch) and negative case testing has more value here and should provide data on the failure modes of the software rather than the probability of failure.
Where stress testing can be useful is in looking at the probability of failure of the infrastructure i.e. network constraints, CPU capacity, storage speed and capacity. Stress testing can provide not only a useful idea of the probability of failure, but should allow users to identify the circumstances (loading) that lead to a particular failure mode and then define sensible limits which should not be exceeded.

Q. Do you think that proper selection of risk analysis technique (like DFMEA, FTA) greatly improves risk management of medical device companies?
A. Yes, absolutely. Both ICH Q9 and ISO 14971 talk about the appropriate selection of appropriate risk assessment models and tools and ICH Q9 Annex I provides a useful discussion on this topic.

Thanks again to everyone who joined us for the webcast and we look forward to catching up for the next webcasts.

No comments: